John Sherwin

799 total citations
24 papers, 529 citations indexed

About

John Sherwin is a scholar working on Pediatrics, Perinatology and Child Health, Clinical Biochemistry and Plant Science. According to data from OpenAlex, John Sherwin has authored 24 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 6 papers in Clinical Biochemistry and 5 papers in Plant Science. Recurrent topics in John Sherwin's work include Prenatal Screening and Diagnostics (7 papers), Neonatal Health and Biochemistry (5 papers) and Metabolism and Genetic Disorders (5 papers). John Sherwin is often cited by papers focused on Prenatal Screening and Diagnostics (7 papers), Neonatal Health and Biochemistry (5 papers) and Metabolism and Genetic Disorders (5 papers). John Sherwin collaborates with scholars based in United States, Japan and Canada. John Sherwin's co-authors include Fred Lorey, George C. Cunningham, Donald H. Chace, Steven L Hillman, George Cunningham, David Krantz, Terrence Hallahan, J. W. Eastman, William K. Purves and Robert J. Currier and has published in prestigious journals such as PEDIATRICS, PLANT PHYSIOLOGY and American Journal of Obstetrics and Gynecology.

In The Last Decade

John Sherwin

24 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Sherwin United States 13 204 179 170 92 91 24 529
William P. Winter United States 13 99 0.5× 35 0.2× 134 0.8× 157 1.7× 259 2.8× 27 540
F. L. Warren United Kingdom 11 121 0.6× 60 0.3× 132 0.8× 48 0.5× 59 0.6× 18 593
A Kappas United States 10 169 0.8× 29 0.2× 373 2.2× 34 0.4× 28 0.3× 10 473
R Guthrie United States 9 34 0.2× 94 0.5× 178 1.0× 16 0.2× 13 0.1× 17 356
Ross B. Gordon Australia 12 36 0.2× 117 0.7× 246 1.4× 34 0.4× 7 0.1× 20 547
A. William Shafer United States 12 90 0.4× 25 0.1× 115 0.7× 37 0.4× 23 0.3× 21 574
V. Schwarz United Kingdom 13 159 0.8× 279 1.6× 185 1.1× 12 0.1× 25 0.3× 38 805
Roichi Itoh Japan 16 260 1.3× 38 0.2× 403 2.4× 11 0.1× 8 0.1× 39 699
Nataša Karas Kuželički Slovenia 14 150 0.7× 40 0.2× 156 0.9× 41 0.4× 21 0.2× 42 489
Andrew Deiss United States 9 42 0.2× 21 0.1× 96 0.6× 138 1.5× 93 1.0× 13 426

Countries citing papers authored by John Sherwin

Since Specialization
Citations

This map shows the geographic impact of John Sherwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Sherwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Sherwin more than expected).

Fields of papers citing papers by John Sherwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Sherwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Sherwin. The network helps show where John Sherwin may publish in the future.

Co-authorship network of co-authors of John Sherwin

This figure shows the co-authorship network connecting the top 25 collaborators of John Sherwin. A scholar is included among the top collaborators of John Sherwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Sherwin. John Sherwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, Mark I., David Krantz, Terrence Hallahan, John Sherwin, & David W. Britt. (2013). Quality of Nuchal Translucency Measurements Correlates with Broader Aspects of Program Rigor and Culture of Excellence. Fetal Diagnosis and Therapy. 33(4). 230–234. 2 indexed citations
2.
Krantz, David, et al.. (2011). First-trimester screening in triplets. American Journal of Obstetrics and Gynecology. 205(4). 364.e1–364.e5. 6 indexed citations
3.
Krantz, David, et al.. (2011). First trimester Down syndrome screening with dried blood spots using a dual analyte free beta hCG and PAPP‐A immunofluorometric assay. Prenatal Diagnosis. 31(9). 869–874. 18 indexed citations
4.
Evans, Mark I., David Krantz, Terrence Hallahan, & John Sherwin. (2011). Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance. Ultrasound in Obstetrics and Gynecology. 39(2). 181–184. 16 indexed citations
5.
Krantz, David, Terrence Hallahan, & John Sherwin. (2010). Screening for Open Neural Tube Defects. Clinics in Laboratory Medicine. 30(3). 721–725. 14 indexed citations
6.
Evans, Mark I., David Krantz, Terrence Hallahan, & John Sherwin. (2010). Undermeasurement of Nuchal Translucencies: Implications for Screening. Obstetrics and Gynecology. 116(4). 815–818. 16 indexed citations
7.
Evans, Mark L., et al.. (2009). 357: Skewed to the left: under-measurement of NT's and implications for screening efficiency. American Journal of Obstetrics and Gynecology. 201(6). S140–S140. 3 indexed citations
8.
Pass, Kenneth A., Nancy Green, Fred Lorey, John Sherwin, & Anne Marie Comeau. (2006). Pilot programs in newborn screening. Mental Retardation and Developmental Disabilities Research Reviews. 12(4). 293–300. 21 indexed citations
9.
Ferber, Matthew J., Brittany Dawson, Robert M. Jacobson, et al.. (2006). Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease. Molecular Genetics and Metabolism. 89(1-2). 134–138. 41 indexed citations
10.
Feuchtbaum, Lisa, et al.. (2006). California's Experience Implementing a Pilot Newborn Supplemental Screening Program Using Tandem Mass Spectrometry. PEDIATRICS. 117(Supplement_3). S261–S269. 34 indexed citations
11.
Wong, Lee-Jun, Suzanne Young, Michelle Pearl, et al.. (2004). Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Human Mutation. 24(4). 353–353. 33 indexed citations
12.
Lorey, Fred, George Cunningham, Elliott Vichinsky, et al.. (2001). Universal Newborn Screening for Hb H Disease in California. Genetic Testing. 5(2). 93–100. 78 indexed citations
13.
Eastman, J. W., John Sherwin, Ruth Wong, et al.. (2000). Use of the phenylalanine:tyrosine ratio to test newborns for phenylketonuria in a large public health screening programme. Journal of Medical Screening. 7(3). 131–135. 24 indexed citations
14.
Eastman, J. W., et al.. (1999). Distribution of Hemoglobin F, A, S, C, E, and D Quantities in 4 Million Newborn Screening Specimens. Clinical Chemistry. 45(5). 683–685. 10 indexed citations
15.
Natelson, Samuel, et al.. (1978). On the biosynthesis of guanidinosuccinate.. Clinical Chemistry. 24(12). 2108–2114. 7 indexed citations
16.
Sherwin, John & Solon A. Gordon. (1974). The effect of auxin on the incorporation of [3H]thymidine into the DNA of pea epicotyls. Planta. 116(1). 65–72. 3 indexed citations
17.
Sherwin, John & Solon A. Gordon. (1974). Linear Velocity of Cyclic Adenosine 3′,5′-Monophosphate Transport in Corn Coleoptiles. PLANT PHYSIOLOGY. 53(3). 416–418. 2 indexed citations
18.
Sherwin, John & Masaki Furuya. (1973). A Red-Far Red Reversible Effect on Uptake of Exogenous Indoleacetic Acid in Etiolated Rice Coleoptiles. PLANT PHYSIOLOGY. 51(2). 295–298. 10 indexed citations
19.
Sherwin, John. (1970). A tryptophan decarboxylase from cucumber seedlings. Plant and Cell Physiology. 11(6). 865–872. 11 indexed citations
20.
Sherwin, John & William K. Purves. (1969). Tryptophan as an Auxin Precursor in Cucumber Seedlings. PLANT PHYSIOLOGY. 44(9). 1303–1309. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026